Selecta Biosciences Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Selecta Biosciences (SELB) IPO Opens, Trades Modestly Higher
June 22, 2016 11:36 AM EDTToday's IPO for Selecta Biosciences (NASDAQ: SELB) opened earlier at $15 after pricing 5,000,000 shares of common stock at a public offering price of $14.00 per share, the low end of the expected $14 to $16 range. Shares last traded up 3.8% to $14.53.
UBS Investment Bank and Stifel are acting as joint book-running managers for the offering. Canaccord Genuity and Needham & Company are acting as co-managers for the offering.
Selecta Biosciences is a clinical-stage biopharmaceutical company using its proprietary synthetic vaccine particle, or SVP, technology to discover and develop targeted... More
